AGAPE ATP CORPORATION Investment Owned, at Cost
AGAPE ATP CORPORATION (ATPC) had Investment Owned, at Cost of $16.69 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes
us-gaap:InvestmentOwnedAtCost · last filed 2024-04-01
- 2023-12-31: Investment Owned, at Cost $16.69K.
- 2023-09-30: Investment Owned, at Cost $16.69K.
- 2023-06-30: Investment Owned, at Cost $16.69K.
- 2023-03-31: Investment Owned, at Cost $16.69K.
| Period end | Investment Owned, at Cost |
|---|---|
| 2023-12-31 | $16.69K 10-K · filed 2024-04-01 |
| 2023-09-30 | $16.69K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $16.69K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $16.69K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $89.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $89.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $89.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $89.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $577.03K 10-K · filed 2023-03-31 |
| 2021-09-30 | $577.03K 10-Q/A · filed 2022-07-05 |
| 2021-06-30 | $577.03K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $577.03K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $66.48K 10-Q/A · filed 2022-07-05 |
| 2020-09-30 | $66.48K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $66.48K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $134.17K 10-K · filed 2021-03-31 |
| 2019-03-31 | $832.34K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $832.34K 10-Q · filed 2019-02-15 |
| 2018-09-30 | $862.49K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $862.49K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |